Jože Colaric

Chief Executive Officer at KRKA, D. D.

68 year

Health Technology

Consumer Services

Profile

Jože Colaric is currently the Chairman-Management Board & CEO at KRKA dd since 2005 and the Chairman & Chief Executive Officer at KRKA Farmaceutici Milano SRL since 2004.
He completed his undergraduate degree at the University of Ljubljana in 1979.

Jože Colaric active positions

Companies	Position	Start
KRKA, D. D.	Chief Executive Officer	2004-12-31
KRKA Farmaceutici Milano SRL KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.	Chief Executive Officer	2004-07-11

All active positions of Jože Colaric

Training of Jože Colaric

University of Ljubljana

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jože Colaric's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
KRKA, D. D.	Health Technology

Private companies	1
KRKA Farmaceutici Milano SRL KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.	Health Technology